---
title: 'Childhood Langerhans cell histiocytosis hematological involvement: severity
  associated with BRAFV600E loads'
date: '2024-11-01'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39486044/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20241101195434&v=2.18.0.post9+e462414
source: Blood
description: 'Hematological involvement (HI) is one of the life-threatening risk organs
  (ROs) in Langerhans cell histiocytosis (LCH). Lahey criteria have defined HI since
  1975 as hemoglobin <10 g/dL and/or platelets <100 G/L and/or leukopenia (white blood
  cell count <4 G/L) and/or neutrophils <1.5 G/. Among the 2313 patients <18 years
  old enrolled in the French National Histiocytosis Registry (1983-2023), 331 developed
  HI (median age at diagnosis: 1 year); median follow-up lasted 8.1 years. ...'
disable_comments: true
---
Hematological involvement (HI) is one of the life-threatening risk organs (ROs) in Langerhans cell histiocytosis (LCH). Lahey criteria have defined HI since 1975 as hemoglobin <10 g/dL and/or platelets <100 G/L and/or leukopenia (white blood cell count <4 G/L) and/or neutrophils <1.5 G/. Among the 2313 patients <18 years old enrolled in the French National Histiocytosis Registry (1983-2023), 331 developed HI (median age at diagnosis: 1 year); median follow-up lasted 8.1 years. ...